U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07318363) titled 'IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention' on Dec. 29, 2025.
Brief Summary: This trial aims to implement and compare an evidence- and theory-based intervention strategy (IGNITE-TX Intervention) to support probands and their ARRs in family communication, informed decision-making, and navigation to CGT with standard of care, free genetic testing/counseling, and intervention with free genetic testing/counseling.
Study Start Date: June 01, 2026
Study Type: INTERVENTIONAL
Condition:
Communication
Informed Decision-making
Intervention:
OTHER: IGNITE-TX program
Participants will compl...